This aid is part of the eighth call for the Gilead–Spanish Association for the Study of the Liver Grants, which supports initiatives to improve the detection and management of these diseases within the National Health System.

The selected project, named MICROVIHEP-DENIA, is a collaboration between the department's Infectious Diseases Unit and the Digestive Medicine Service. Its objective is the micro-elimination of viral hepatitis and HIV through automated screening and care linkage.

The initiative is based on an automated screening system in Primary Care. This system leverages analytics requested for other reasons to automatically detect viral hepatitis and HIV in individuals aged between 40 and 80 years. This allows for the identification of undiagnosed infections, promotes early diagnosis, and facilitates immediate referral to specialized services for treatment.

Furthermore, the project reduces diagnostic times, minimizes follow-up losses, and improves coordination between care levels. This has a significant impact on public health, contributing to the identification of undiagnosed patients and advancing towards the elimination goals for these infections set by the World Health Organization for 2030.

The project will last 24 months, during which its effectiveness and potential application in other healthcare settings will be evaluated. Since their creation in 2018, the Gilead–AEEH Grants have funded 90 projects across 16 autonomous communities, with over 2.2 million euros allocated to research initiatives.